Alessandro Perez

Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients

Francesco Passiglia, Antonio Galvano, Marta Castiglia et al. · Therapeutic Advances in Medical Oncology · 2019 · 64 citations · Full text

Role and importance of polymorphisms with respect to DNA methylation for the expression of CYP2E1 enzyme

Flores Naselli, Irene Catanzaro, Daniele Bellavia et al. · Gene · 2013 · 35 citations · Full text

Medicine, Genetics, Dna Methylation +9

Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—a trial-level meta-analysis in PD-L1 selected subgroups

Francesco Passiglia, Antonio Galvano, Valerio Gristina et al. · Translational Lung Cancer Research · 2021 · 32 citations · Full text

Spheroids from adipose‐derived stem cells exhibit an miRNA profile of highly undifferentiated cells

Anna Barbara Di Stefano, Federica Grisafi, Marta Castiglia et al. · Journal of Cellular Physiology · 2018 · 26 citations

Not all <i>KIT</i> 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)

Lorena Incorvaia, Giuseppe Badalamenti, Daniele Fanale et al. · Therapeutic Advances in Medical Oncology · 2021 · 24 citations · Full text